This episode of Carver's Middle East Regulatory Updates delves into critical topics such as Pharmacovigilance, Labelling, and Packaging Defects impacting the pharmaceutical sector, with additional focus on regulatory frameworks involving the Ministerio para la Transición Ecológica y el Reto Demográfico and the State Water Resources Control Board.

The Saudi Food and Drug Authority (SFDA) has issued a notification concerning a packaging defect affecting batch number 010524 of the pharmaceutical product ألفاكالسيدول. The defect centers on missing Arabic and English labeling on the packaging, prompting the SFDA to provide an English package leaflet as a corrective measure. Healthcare professionals are advised to review this leaflet thoroughly and counsel patients accordingly to prevent misuse.

This update underscores the importance of accurate labelling and patient information in safeguarding public health and maintaining regulatory compliance within the pharmacovigilance domain.

For more information, visit the Carver Agents website.

Articles mentioned:

1. ألفاكالسيدول